Biomarker Services
Overview |
 |
Whether in preclinical or Phase III, biomarkers can help increase the success rate of any drug development program, in terms of speed, cost and quality. In early drug development, biomarkers help identify viable drug targets by predicting early toxicological effects. During late stage clinical trials, they help prove drug safety and effectiveness, guide trial design and support critical decision making. As a result of their proven utility and also future promise, biomarkers are being increasingly embraced by the medical and regulatory community.
To support your drug development needs, Covance provides a full suite of biomarker assay development and validation services as well as biomarker testing services (both large and small scale) across the drug development continuum, from early proof of concept to commercial laboratory testing: |
|
- Preclinical through Proof of Concept — antibody development; assay development, validation and reporting, biomarker testing
- Phase IIb through Commercialization — assay development, validation and reporting; assay production, and biomarker testing
As the world's largest biomarker testing company supporting drug development, we can provide you with:
Expert guidance — through our biomarker expert panel that spans all stages of drug development
Confidence — that your needs will be met, on time and with accurate data; as no other CRO runs more drug-development related biomarker tests than Covance.
Flexibility — to support all of your needs with our broad range of biomarker technology platforms
Global support — with our presence and resources covering every major geography |
|
|
